All In Biotech

Drug Trial Radar · NCT07393165

Levothyroxine Treatment on Cardiac Function in Children With Subclinical Hypothyroidism

The Effect of Levothyroxine Treatment on Cardiac Function in Children With Subclinical Hypothyroidism

Last checked: Nov 20, 2026Latest source record: Feb 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

May 24, 2025

Primary completion

May 1, 2026

Study completion May 1, 2026

Sponsor

Lead sponsor
Tanta UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 6, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 4 years, up to 15 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to evaluate the effect of the treatment with levothyroxine on cardiac function in children with subclinical hypothyroidism.

Conditions

  • Levothyroxine
  • Cardiac Function
  • Children
  • Subclinical Hypothyroidism

Interventions

  • L-thyroxineDrug

    Children with subclinical hypothyroidism who will receive L-thyroxine treatment in a dose of 2μg/kg/d (the smallest dose can be given) and the dose will be titrated every 4 weeks until a normal thyroid-stimulating hormone (TSH) level is maintained.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Assessment of left ventricle systolic functionTime frame: 3 months post-procedure

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Tanta University

    Tanta, El-Gharbia, Egypt · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.